RXRA and cancer: Studies have observed the inhibitory effects of PPARγ-RXRα signaling pathway on tumor growth, angiogenesis, differentiation, and that of production of inflammatory cytokines and tumor invasiveness, suggesting the anti-tumorigenic role of PPARγ in several cancer types including colon, lung, pancreas, prostate, and breast cancer [11,45].